WEKO3
アイテム
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors
http://hdl.handle.net/2241/00159740
http://hdl.handle.net/2241/00159740b561b546-7eac-4646-8408-51f208bd2d40
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
Item type | Journal Article(1) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
公開日 | 2020-03-17 | |||||||||||
タイトル | ||||||||||||
タイトル | Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors | |||||||||||
言語 | ||||||||||||
言語 | eng | |||||||||||
資源タイプ | ||||||||||||
資源タイプ | journal article | |||||||||||
アクセス権 | ||||||||||||
アクセス権 | open access | |||||||||||
著者 |
兵頭, 一之介
× 兵頭, 一之介
WEKO
713
× Shitara, Kohei× Satoh, Taroh× Iwasa, Satoru× Yamaguchi, Kensei× Muro, Kei× Komatsu, Yoshito× Nishina, Tomohiro× Esaki, Taito× Hasegawa, Jun× Kakurai, Yasuyuki× Kamiyama, Emi× Nakata, Tomoko× Nakamura, Kota× Sakaki, Hayato |
|||||||||||
書誌情報 |
en : Journal for ImmunoTherapy of Cancer 巻 7, p. 219, 発行日 2019-08 |
|||||||||||
ISSN | ||||||||||||
収録物識別子タイプ | EISSN | |||||||||||
収録物識別子 | 2051-1426 | |||||||||||
DOI | ||||||||||||
関連タイプ | isIdenticalTo | |||||||||||
関連識別子 | https://doi.org/10.1186/s40425-019-0679-9 | |||||||||||
PMID | ||||||||||||
関連識別子 | 31412935 | |||||||||||
権利情報 | ||||||||||||
権利情報 | © The Author(s). 2019 Open Access | |||||||||||
権利情報 | ||||||||||||
権利情報 | This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. | |||||||||||
出版タイプ | ||||||||||||
出版タイプ | VoR | |||||||||||
出版者 | ||||||||||||
出版者 | BMC |